First Time Loading...
B

Beijing Tiantan Biological Products Corp Ltd
SSE:600161

Watchlist Manager
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Watchlist
Price: 30.4 CNY 1.3% Market Closed
Updated: May 9, 2024
Section:
 

Relative Value

The Relative Value of one Beijing Tiantan Biological Products Corp Ltd stock under the Base Case scenario is 39.67 CNY. Compared to the current market price of 30.4 CNY, Beijing Tiantan Biological Products Corp Ltd is Undervalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
39.67 CNY
Undervaluation 23%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

9.7
P/S
P/S
Price to Sales
9.7
vs History
33
vs Industry
49
Median 3Y
9
Median 5Y
9
Industry
8.3
Forward
8
More Details
45.1
P/E
P/E
Price to Earnings
45.1
vs History
47
vs Industry
4
Median 3Y
43.5
Median 5Y
44.3
Industry
26.8
Forward
36.7
More Details
20.9
P/OCF
P/OCF
Price to OCF
20.9
vs History
84
vs Industry
8
Median 3Y
30.5
Median 5Y
33.5
Industry
23.3
More Details
52.7
P/FCFE
P/FCFE
Price to FCFE
52.7
vs History
31
vs Industry
4
Median 3Y
-80.5
Median 5Y
35.9
Industry
21.4
More Details
5.1
P/B
P/B
Price to Book Value
5.1
vs History
55
vs Industry
17
Median 3Y
4.8
Median 5Y
5.2
Industry
2.6
More Details
9.2
EV/S
EV/S
Enterprise Value to Sales
9.2
vs History
31
vs Industry
40
Median 3Y
8.4
Median 5Y
8.4
Industry
7.5
Forward
7.6
More Details
18
EV/GP
EV/GP
Enterprise Value to Gross Profit
18
vs History
41
vs Industry
28
Median 3Y
17.3
Median 5Y
17.4
Industry
9.2
More Details
27.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
27.6
vs History
49
vs Industry
5
Median 3Y
26.1
Median 5Y
26.7
Industry
4.5
Forward
19.7
More Details
27.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
27.6
vs History
49
vs Industry
5
Median 3Y
26.1
Median 5Y
26.7
Industry
4.4
Forward
24.6
More Details
19.8
EV/OCF
EV/OCF
Enterprise Value to OCF
19.8
vs History
82
vs Industry
9
Median 3Y
27.4
Median 5Y
30.5
Industry
5.6
More Details
36
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
36
vs History
46
vs Industry
5
Median 3Y
-151.1
Median 5Y
33.9
Industry
3.4
More Details
4.2
EV/IC
EV/IC
Enterprise Value to IC
4.2
vs History
65
vs Industry
36
Median 3Y
4
Median 5Y
4.6
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
Beijing Tiantan Biological Products Corp Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
50.1B CNY 9.7 45.1 27.6 27.6
US
Abbvie Inc
NYSE:ABBV
283.3B USD 5.2 58.8 12.8 19.5
US
Amgen Inc
NASDAQ:AMGN
168.3B USD 5.7 44.7 18.8 31
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
108.2B USD 11 29.9 24 25.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
106.8B USD 8.2 27.7 22.4 24.8
AU
CSL Ltd
ASX:CSL
133.8B AUD 6.2 35.6 21.6 26.7
US
Gilead Sciences Inc
NASDAQ:GILD
80.5B USD 2.9 166.4 6.7 8.7
US
Moderna Inc
NASDAQ:MRNA
47.3B USD 9.2 -7.9 -8.6 -7.7
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
32.4B USD 3.4 27.8 14.2 17.7
KR
Celltrion Inc
KRX:068270
39.3T KRW 18.1 73.4 44.9 61.8

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.